Chemoinformaics analysis of 3,4-DIMETHYL-2,5-DIOXO-2,5-DIHYDROTHIOPHENE
| Molecular Weight | 142.179 | nRot | 0 |
| Heavy Atom Molecular Weight | 136.131 | nRig | 7 |
| Exact Molecular Weight | 142.009 | nRing | 1 |
| Solubility: LogS | -2.405 | nHRing | 1 |
| Solubility: LogP | 1.933 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 15 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 18.5248 |
| nHD | 0 | BPOL | 10.2152 |
| QED | 0.508 |
| Synth | 3.426 |
| Natural Product Likeliness | -0.194 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0 |
| HIA | 0.011 |
| CACO-2 | -4.472 |
| MDCK | 0.0000257 |
| BBB | 0.206 |
| PPB | 0.733531 |
| VDSS | 1.028 |
| FU | 0.298886 |
| CYP1A2-inh | 0.928 |
| CYP1A2-sub | 0.756 |
| CYP2c19-inh | 0.465 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.163 |
| CYP2c9-sub | 0.889 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.605 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.15 |
| CL | 8.909 |
| T12 | 0.299 |
| hERG | 0.009 |
| Ames | 0.128 |
| ROA | 0.87 |
| SkinSen | 0.929 |
| Carcinogencity | 0.605 |
| EI | 0.991 |
| Respiratory | 0.846 |
| NR-Aromatase | 0.226 |
| Antiviral | No |
| Prediction | 0.934361 |